Oral Abstract Session
AKI Predictors and Outcomes: Research Abstracts
October 23, 2020 | 05:00 PM - 07:00 PM
Location: Simulive
Session Description
Oral Abstract Session
Learning Pathway(s)
- Acute Kidney Injury
Moderator
- Alexander Bullen, MD
Presentations
- Terlipressin Improves Renal Replacement Therapy–Free Survival in Hepatorenal Syndrome Type 1
05:00 PM - 07:00 PM
Juan Carlos Q. Velez, MD, FASN
- A Parsimonious Model for Diagnosis of Biopsy-Proven Acute Interstitial Nephritis Using Electronic Health Record Data
05:00 PM - 07:00 PM
Dennis G. Moledina, MD, PhD
- Development and Validation of a Convolutional Neural Network Model for Intensive Care Unit AKI Prediction
05:00 PM - 07:00 PM
Jacob Calvert, MS
- Outcomes from the Use of the Selective Cytopheretic Device (SCD) in Critically Ill Children Receiving CRRT: A Report of the Multicenter Pediatric SCD (pSCD) Study
05:00 PM - 07:00 PM
Stuart Goldstein, MD, FASN
- Nicotinamide Riboside with Pterostilbene Increases NAD<sup>+</sup> in Patients with AKI: A Randomized, Double-Blind, Placebo-Controlled, Stepwise Safety Study of NRPT in Patients with AKI
05:00 PM - 07:00 PM
Petra Simic, MD, PhD
- Role of Angiopoietins in CKD Progression After Hospitalization
05:00 PM - 07:00 PM
Sherry Mansour, MD, MS
- Determinants of Major Adverse Kidney Events (MAKE) in Extra Corporeal Membrane Oxygenation (ECMO) Survivors
05:00 PM - 07:00 PM
Aniesh Bobba, MD
- AKI Among African Americans with Sickle Cell Trait and Disease
05:00 PM - 07:00 PM
Kabir O. Olaniran, MD, MPH
- Assessment of Kidney Proximal Tubular Secretion in Critical Illness
05:00 PM - 07:00 PM
Pavan K. Bhatraju, MD, MS
- Endotrophin, Released During Collagen Type VI Formation, Predicts Long-Term Mortality After AKI
05:00 PM - 07:00 PM
Nadja Sparding